Skip to main content
Beta-arrestin inhibition to prevent S1P1 internalization as a treatment for intracranial diseases

Beta-arrestin inhibition to prevent S1P1 internalization as a treatment for intracranial diseases

Value Proposition Glioblastomas (GBMs) are among the most common and deadly malignant brain tumors with a mean survival time of approximately 14-15 months following diagnosis. Current treatments for GBMs include surgery, radiation, and chemotherapy, however,…

Read More

Method of deep brain stimulation for use in treating Parkinson’s Disease

Method of deep brain stimulation for use in treating Parkinson’s Disease

Value Proposition Parkinson’s disease is a common neurodegenerative disorder that progressively deteriorates the motor system. With over seven million people afflicted globally and a rising incidence rate, improved treatment options for Parkinsonian symptoms will be…

Read More

Suppression of neuropathic pain by intrathecal delivery of bone marrow stem cells

Suppression of neuropathic pain by intrathecal delivery of bone marrow stem cells

Value proposition Neuropathic pain is a chronic, often debilitating condition caused by damage or injury to the nerves. Neuropathic pain is a common condition that result from various conditions trauma, viral infections, cancer, neurological conditions…

Read More

Magnetic resonance imaging method for detecting magnetic field oscillations

Magnetic resonance imaging method for detecting magnetic field oscillations

This invention is a new magnetic resonance imaging method that can detect magnetic field oscillations in specific frequency bands, in particular those induced by neuroelectric activity in the brain. In contrast to existing neuroimaging techniques,…

Read More

Mouse model of cholinergic dysfunction to evaluate cognitive enhancers for Alzheimer’s disease treatment

Mouse model of cholinergic dysfunction to evaluate cognitive enhancers for Alzheimer’s disease treatment

Value Proposition Defects in acetylcholine transmission have been associated with several major neurodegenerative disorders including Alzheimer’s disease, dementia, cerebral palsy, Parkinson’s disease, Huntington’s disease and myasthenia gravis. Although cholinergic dysfunction has been implicated in these…

Read More

Shank3 knockout mice as a model for autism

Shank3 knockout mice as a model for autism

The Shank3B- knockout allele has a neo cassette replacing the PDZ domain (exons 13-16) of the Shank3 gene, resulting altered expression of the Shank3b isoform. These mice may be useful for studying behavioral abnormalities associated…

Read More

Miniaturized, ultra-high density, multichannel electrode array for long-term, intra-cranial neuronal recordings

Miniaturized, ultra-high density, multichannel electrode array for long-term, intra-cranial neuronal recordings

Technology A high-density multichannel microwire electrode array is disclosed. The array can comprise a variable number of electrodes. A method of assembling the array is further disclosed. Additionally, a plurality of devices employing the array…

Read More

Model-based optimization of spinal cord stimulation parameters

Model-based optimization of spinal cord stimulation parameters

Value Proposition Spinal cord stimulation (SCS) is an FDA approved therapy for treating chronic lower back and limb pain. SCS is based on the gate control theory of pain, where an implanted pulse generator delivers…

Read More

Passive pressure sensor

Passive pressure sensor

Value proposition Monitoring Intracranial Pressure (ICP) in patients undergoing neurological conditions is critical in tracking progress and recovery. In conditions such as hydrocephalus, a shunt is used to allow extra cerebrospinal fluid to drain. These…

Read More

Novel dystonia treatment drugs

Novel dystonia treatment drugs

Value Proposition Dystonia is a movement disorder characterized by sustained, often painful involuntary postures, causing motor disabilities and a marked decrease in quality of life. Dystonia is the third most common movement disorder behind Parkinson’s…

Read More

Conjugated neuroactive steroid compositions and methods of use thereof

Conjugated neuroactive steroid compositions and methods of use thereof

The present disclosure provides modified neuroactive steroids. The modified neuroactive steroids may comprise, consist of, or consist essentially of a therapeutic agent and/or a modifying moiety. The modified neuroactive steroid can have modified characteristics as…

Read More

A novel target for therapeutic intervention of muscle atrophy

A novel target for therapeutic intervention of muscle atrophy

The present invention provides methods and compositions for modulating HDAC4 activity and modulating the activity of proteins downstream of HDAC4 in the muscle transcriptional pathway in a cell by modulating HDAC4 activity. Further provided are…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us